Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upsher-Smith Laboratories LLC

Division of Sawai Pharmaceutical Co. Ltd.
www.upsher-smith.com

Latest From Upsher-Smith Laboratories LLC

US Generics Market Continues To Seek Stability

As the US generics market continues to experience turbulence, the industry’s largest players are adopting a wide range of strategies to cope with the uncertainty as signs of stabilization begin to emerge.

Market Intelligence Generic Drugs

One-Offs Lift Dr Reddy’s In Q2

One-offs aided Dr Reddy’s performance in the second quarter although US growth was flat amid challenges including the recall of ranitidine. But the Indian firm is enthused about fresh potential opportunities for generic Suboxone in the US in view of Indivior’s intent to discontinue its authorized generic.

Strategy Sales & Earnings

One-offs Lift Dr Reddy’s In Q2, Eyes Gx Suboxone Opportunities

One-offs aided Dr Reddy’s performance in the second quarter although US growth was flat amid challenges including the recall of ranitidine. But the Indian firm is enthused about fresh potential opportunities for generic Suboxone in the US in view of Indivior’s intent to discontinue its authorized generic.

Commercial Sales & Earnings

Opioid Blister Packs Need Study Before Mandate, Groups Urge

AAM, Upsher-Smith, APhA, and Cigna tell US FDA that packaging requirement will increase manufacturing and drug costs, create reimbursement hurdles and reduce access to medicines. Daiichi-Sankyo supports agency's proposal.

Drug Safety Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Metabolic Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Upsher-Smith Laboratories Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sawai Pharmaceutical Co. Ltd.
  • Senior Management
  • Mark Evenstad, CEO
    Richard P Fisher, SVP, Corp. Strategy
    Sami Yusuf, VP, Corp. Dev.
  • Contact Info
  • Upsher-Smith Laboratories LLC
    Phone: (800) 654-2299
    6701 Evenstad Dr.
    Maple Grove, MN 55369
    USA
UsernamePublicRestriction

Register